J&J to acquire psychiatric drugs maker Intra-Cellular for $14.6 billion

J&J will pay $132 a share, the company said in a statement. That's 39% above the closing price Friday. Bloomberg earlier reported a deal was in the works. Shares of Intra-Cellular rose 36% to $128.72 in trading before the market opened in New York. The stock has gained about 40% over the last 12 months, giving the company a market value of roughly $10 billion.

from International-News-Economic Times https://ift.tt/iCFRn9m

SHARE